Corentec Co

Corentec Co Operating Cash Flow

The Operating Cash Flow of Corentec Co (104540.KQ) as of Oct 16, 2026 is 26.46 B KRW. In the previous year, Operating Cash Flow was -6.61 B KRW — a change of -500.52% (higher).

Operating Cash Flow

26.46 BKRW

YoY

-500.52%

Last updated:

Operating Cash Flow of Corentec Co is 2025 26.46 B KRW. Operating Cash Flow of Corentec Co was 2024 -6.61 B KRW. It decreases by -500.52% higher compared to the previous year.

The Corentec Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
5.26 B KRW
Jan 1, 2019
3.86 B KRW
Jan 1, 2020
-3.61 B KRW
Jan 1, 2021
4.08 B KRW
Jan 1, 2022
10.60 B KRW
Jan 1, 2023
2.63 B KRW
Jan 1, 2024
-6.61 B KRW
Jan 1, 2025
26.46 B KRW
The Corentec Co Operating Cash Flow history
YEAROperating Cash FlowYoY
26.46 BKRW-500.52%
-6.61 BKRW-350.76%
2.63 BKRW-75.15%
10.60 BKRW+160.06%
4.08 BKRW-212.97%
-3.61 BKRW-193.58%
3.86 BKRW-26.69%
5.26 BKRW-10.29%
5.86 BKRW+99.26%
2.94 BKRW+15.62%
2.54 BKRW+464.59%
450.70 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Operating Cash Flow of Corentec Co is 26.46 B KRW in 2025.

Operating Cash Flow of Corentec Co changed from -6.61 B KRW to 26.46 B KRW, representing a -500.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co